Antihypertensive Therapeutics in Major Developed Market Analysis and Treatment, 2021: Hexa Reports

Submitted by: Submitted by

Views: 10

Words: 776

Pages: 4

Category: Business and Industry

Date Submitted: 05/15/2016 11:58 PM

Report This Essay

Hexa Reports

Market Research Reports and Insightful Company Profiles

Antihypertensive Therapeutics in Major Developed Market

Size, Share, Growth, Treatment, Analysis, Symptoms,

Emerging Trends and Opportunities to 2021

Hypertension is a heart-related disease which results in elevated blood pressure in the arteries. It is also

known as arterial hypertension or high blood pressure. This disease occurs on account of alcohol,

smoking, obesity, and other genetic factors. Although, the disease can be treated with a healthy diet and

exercise, antihypertensives are recommended to control it.

Antihypertensives are a class of drugs which can prevent hypertension and other cardiovascular-related

disorders like strokes and myocardial infarction. They are likely to reduce the heart conditions by 21%.

Beta blockers, thiazide diuretics, ACE inhibitors, calcium channel blockers, and angiotensin II receptor

antagonists (ARBs) are the different types of antihypertensive therapeutics in major developed markets.

Browse Detail Report With TOC @ http://www.hexareports.com/report/antihypertensivetherapeutics-in-major-developed-markets/details

Thiazide diuretics aid in reducing salt and water from the kidneys. They are the first drugs to be

administered for a patient undergoing hypertension treatment. ACE inhibitors reduce serum creatinine

levels better than beta blockers. They are considered the first line of defense against heart-related

disorders. ARBs reduces the risko f myocardial infarction when combined with amlodipine. Beta blockers

Hexa Reports

Market Research Reports and Insightful Company Profiles

are considered risky and can lead to strokes or type-2 diabetes. However, they prevent heart attacks in

persons who have already experienced a heart attack.

The hypertension market was estimated to have earned USD 40 billion of revenue in 2013. The market

will attain USD 37 billion by 2020, owing to the patent expiry of major drugs. It is predicted to...